Table 1 Demographic and clinical characteristics of SLE patients. Continuous variables are represented as mean ± standard deviation (SD)
Characteristics | SLE patients (n = 41) |
|---|---|
Demographic characteristics | |
Female/male | 37/4 |
Age (year) | 31.6 ± 13.2 |
Clinical features | |
Disease duration (year) | 6.0 ± 7.0 |
SLEDAI | 8.2 ± 6.0 |
Inactive patients (n) (%) | 14 (34.1) |
Active patients (n) (%) | 27 (65.9) |
Clinical manifestations (n) (%) | |
Rash | 24 (58.5) |
Oral ulcers | 3 (7.3) |
Alopecia | 18 (43.9) |
Arthritis | 16 (39.0) |
Pleuritis | 2 (4.9) |
Nephritis | 24 (58.5) |
Hematological disorders | 19 (46.2) |
Neurologic disorders | 1 (2.4) |
Pericarditis | 0 |
Fever | 0 |
Serological features | |
Serum complement C3 (mg/L) | 668.4 ± 351.6 |
Serum complement C4 (mg/L) | 133.9 ± 149.8 |
ESR (mm/h) | 51.0 ± 34.4 |
Total bilirubin (µmol/L) | 8.9 ± 4.9 |
Serum creatinine (µmol/L) | 79.7 ± 39.5 |
Urine protein (g/24 h) | 2.39 ± 4.55 |
Anti-dsDNA positive (n) (%) | 11 (26.8) |
Anti-Sm positive (n) (%) | 11 (26.8) |
Anti-SSA positive (n) (%) | 26 (63.4) |
Anti-nucleosome positive (n) (%) | 15 (36.6) |
Current therapy (n) (%) | |
Glucocorticoids | 31 (75.6) |
Immunosuppressants | 10 (24.4) |